Skip to main content

2025 AGENDA

Friday, May 2nd, 2025

6:00 – 9:30 PM Registration
7:00 PM Welcome Address Dr. Christian Kollmannsberger, GUTG Chair
7:15 – 9:30 PM Welcome Dinner Reception English Bay Room

Saturday, May 3rd, 2025

All Sessions Include 25% of Time for Question Periods and Audience Participation 

7:00 – 8:00 AM Breakfast English Bay Room
8:00 – 8:05 AM Welcoming Remarks for Day 1 – Dr. Krista Noonan, GUTG Systemic Chair Grand Ballroom

Prostate Session
Chairs: Drs.
Nikita Ivanov, Param Bains, Arthur Cheung & Chris Hoag

8:00 – 8:20 AM Novel Diagnostic Tools and Novel Local Therapy Approaches in Localized Prostate Cancer Dr. Miles Mannas
8:20 – 8:25 AM Questions & Answers with the Audience
8:25 – 8:45 AM Systemic Management of Localized Prostate Cancer: High-Risk Localized, Biochemical Recurrence: ARPI for Non-Metastatic Prostate Cancer Dr. Howard Pai
8:45 – 8:50 AM Questions & Answers with the Audience
8:50 – 9:10 AM Managing mCSPC Now and in the Future Dr. Kim Chi
9:10 – 9:15 AM Questions & Answers with the Audience
9:15 – 9:35 AM Panel: Choosing the Right ARPI for the Right Patient: D/D Interactions, Toxicity, Administration, Monitoring, Case Based Discussion Drs. Sunil Parimi, Juanita Crook & Nathan Hoag
9:35 – 9:40 AM Questions & Answers with the Audience

Special Session: Imaging in Prostate Cancer
Chairs: Drs. Ed Hardy, John Duignan, Abraham Alexander & Justin Lee

9:40 – 10:00 AM Panel: Using PSMA-PET in Clinical Practice: Case Discussions: Different Scenarios, Especially Upstaging: Localized, PSA Relapse, mCSPC, mCRPC Drs. Jim Rose, James Curtis, Ercole Leone
10:00 – 10:05 AM Questions & Answers with the Audience
10:10 – 10:30 AM Imaging of Prostate Cancer: Conventional and Novel Techniques Dr. Silvia Chang
10:30 – 10:35 AM Questions & Answers with the Audience
10:35 – 10:50 AM Health Break & Networking English Bay Room

RCC Session
Chairs: Drs. Shannon King, Jenny Ko, Brian Yang & David Petrik

10:50 – 11:05 AM Mainstream Genetic Testing in RCC: When, What and Why? Jennifer Nuk
11:05 – 11:10 AM Questions & Answers with the Audience
11:10 – 11:30 AM What Next?: Considerations for Second Line Systemic Treatment and Beyond in Metastatic RCC Dr. Daygen Finch
11:30 – 11:35 AM Questions & Answers with the Audience
11:35 – 11:55 AM Variant RCC: Histology, Biology and Management (inc. FH Associated RCC, Medullary RCC….) Dr. Lyly Le
11:55 – 12:00 PM Questions & Answers with the Audience
12:00 – 12:20 PM First-line IO Therapy: Is There an Optimal Duration ? Dr. Maryam Soleimani
12:20 – 12:25 PM Questions & Answers with the Audience
12:30 – 1:15 PM Lunch / Networking / Exhibition English Bay Room

Special Session: Radioligand Therapy in BC
Chairs: Drs. Andrew Attwell, Stacy Miller, Meredith Hunter & Omar Nazif

1:15 – 1:35 PM PSMA-PET Criteria Indication of Lu-PSMA-617 Radiographic Criteria to Assess Response Dr. Patrick Martineau
1:35 – 1:55 PM Delivery / Management – State of Affairs in BC Dr. Don Wilson
1:55 – 2:05 PM Questions & Answers with the Audience

Testis Cancer Session
Chairs: Drs. Matthew Ho,  Jessie Shustik & Ross Halperin

2:05 – 2:25 PM Management of Advanced Refractory Germ Cell Tumours Dr. Archie Angeles
2:25 – 2:30 PM Questions & Answers with the Audience
2:30 – 2:45 PM Closing Remarks for Day 1 Dr. Christian Kollmannsberger, GUTG Chair
7:00 – 9:30 PM BCGU Dinner – Keynote: Grand Ballroom

Sunday, May 4th, 2025

All Sessions Include 25% of Time for Question Periods and Audience Participation 

7:00 – 8:00 AM Breakfast English Bay Room
8:00 – 8:05 AM Welcoming Remarks for Day 2 – Dr. Jack Zheng, GUTG RT Chair Grand Ballroom

Bladder Cancer Session
Chairs: Drs. Nathan Wong, Ardashes Avanessian & Winkle Kwan

8:05 – 8:25 AM Local Staging of Bladder Cancer with Multiparametric MRI (mpMRI) and Vesical Imaging Reporting And Data System (VI-RADS) Dr. Ren Yuan
8:25 – 8:30 AM Questions & Answers with the Audience
8:30 – 8:50 AM Neoadjuvant Therapy in Localised UC: Has the Standard Changed? Dr. Richard Gagnon
8:50 – 8:55 AM Questions & Answers with the Audience

Special Session

8:55 – 9:15 AM Can Findings from Neoadjuvant / Adjuvant Trials be Generalized to Both Cystectomy and Radical Radiation as Local Therapy Dr. Guliz Ozgun
9:15 – 9:20 AM Questions & Answers with the Audience
9:20 – 9:40 AM State of the Art in Radical Radiotherapy of the Bladder Including Preference for a Radiosensitizing Agent? Dr. Hamid Raziee
9:40 – 9:45 AM Questions & Answers with the Audience
9:45 -10:05 AM EV/P and FGFR Toxicities: Overblown Hype or Real Worry – How to Manage Dr. Adam Fundytus
10:05 – 10:10 AM Questions & Answers with the Audience
10:10 – 10:30 AM The Role of ctDNA and Urinary DNA as a Biomarker for Bladder Cancer: Detection, Impact, Potential in Management Dr. Gillian Vanderkhove
10:30 – 10:35 AM Questions & Answers with the Audience
10:35 – 10:55 AM Health Break / Networking / Exhibition / Check-out English Bay Room

Prostate Cancer Session 2: mCRPC
Chairs: Drs. Alice Newman, Jonathan Livergant & John Kinahan

10:55 – 11:15 AM First Line Treatment of mCRPC for ARPI-Naïve Patients Dr. Hayley Roberts
11:15 – 11:20 AM Questions & Answers with the Audience
11:20 – 11:40 AM First-line Therapy for mCRPC post ARPi Dr. Jasna Deluce
11:40 – 11:45 AM Questions & Answers with the Audience
11:45 – 12:05 PM Emerging Therapies in mPC: Immunotherapy, Peace – 3, CAR-T, T-cell Engagers Dr. Corinne Maurice-Dror
12:05 – 12:10 PM Questions & Answers with the Audience
 12:10 – 12:30 PM SABR in Oligomet CRPC Dr. Srinivas Raman
12:30 – 12:35 PM Questions & Answers with the Audience
12:35 PM BCGU Conference Closing Remarks Dr. Christian Kollmannsberger, GUTG Chair